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Abstract
Background: The controlled beating of cilia of the fallopian tube plays an important role in facilitating the
meeting of gametes and subsequently transporting the fertilized egg to its implantation site. Rapid effects
of progesterone on ciliary beat frequency have been reported in the fallopian tubes of cows, but the
identity of the receptors mediating this non-genomic action of progesterone is not known. We recently
identified a member of the non-genomic membrane progesterone receptor family, mPR gamma, as a
candidate for mediating these actions of progesterone. Here, we investigated the possible presence of a
related receptor, mPR beta, in the fallopian tubes of mice and women as well as the possible hormonal
regulation of mPR beta and gamma.
Methods: Western blot and immunohistochemistry with specific antibodies were used to characterize
the expression and cellular localization of the mPRs in mouse and human tissues. Taqman (Quantitative
Polymerase Chain Reaction) assays were used to quantify mRNA levels in the fallopian tubes of two
different mouse models after injections with different hormones and specific antagonists.
Results: In the fallopian tubes of both mouse and human, the expression of mPR beta and mPR gamma
proteins was exclusively found in the ciliated cells. Whereas mPR beta was found on the cilia, mPR gamma
was localized at the base of the same ciliated cells, as previously reported. In gonadotropin-primed mice,
both mPRs genes were down-regulated after an injection with progesterone. Treatment with estradiol
rapidly down-regulated the level of mPR beta mRNA and protein in immature mice. The mPR gamma
protein was down-regulated around the time of ovulation in cycling women, similar to the regulation
observed in mice stimulated to ovulate via gonadotropin injections.
Conclusion: Our findings show the presence and hormonal regulation of two distinct mPRs associated
with the cilia of the fallopian tubes in both mice and women. It is hypothesized that these receptors are
involved in the control of ciliary movement and, thus, gamete transport in the fallopian tubes of mammals.
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Background
The fallopian tube (oviduct) of mammals consists mainly
of muscular, ciliated and secretory cells. A central function
of the fallopian tube is to facilitate gamete transport, ferti-
lization and early embryonic development [1]. Gamete
transport in the fallopian tube is reported to depend on
both smooth muscle contractility and the action of cilia
[2]. However, inhibition of muscle contractility by isopro-
terenol did not affect ovum transport in fallopian tube of
rats [3], and much of the literature supports ciliary activity
as the most important factor regulating gamete transport
rate [4,5]. Sex steroids are involved in the control of gam-
ete transport and ciliary activity in the fallopian tube.
Estradiol (E2) treatment accelerates ovum transport from
72 h to 24 hours in rats [6], facilitates sperm migration
and induces adhesion of spermatozoa to the oviductal
epithelium [7]. Concomitant treatment with progesterone
(P4) blocked E2-induced ovum transport [8], whereas P4
alone retarded the process [8-11]. Progesterone also acts
directly on the sperm membrane to promote sperm motil-
ity [12,13] and induces the acrosome reaction [14]. The
cumulus cells surrounding the travelling ovum is a source
for P4 in humans [15,16], rabbit [17], mouse [18] and pig
[19]. It is possible that P4 secreted from the oocyte cumu-
lus complex acts as a beacon to the cilia of the fallopian
tube, indicating its detailed position [20]. Indeed, under-
standing the underlying mechanism of E2 and P4 action in
the regulation of tubal function is important.
Traditionally, P4 is thought to mediate its effects through
its nuclear receptors, PGR-A and PGR-B, which are often
co-expressed within the same cell [21,22], to alter gene
transcription. Not all effects of P4, however, can be
explained by this classical mechanism of steroid action. It
has been suggested that P4 together with PGR present in
the cytoplasm could initiate a non-genomic signaling cas-
cade [23]. Rapid responses to P4 have also been reported
in tissues or cells naturally lacking nuclear PGR [24,25]
and in Pgr knockout models [26], suggesting an involve-
ment of other non-related receptors. [27]. A few years ago,
a novel family of putative receptors (mPRs), including
mPRα, β and γ, were identified [28,29]. The mPRs belong
to the Class II progestin and adipoQ receptors family
(PAQR) [30,31]. There is a growing set of data, to suggest
a supporting role of the mPRs as functional progestin
receptors in different vertebrates, although there are still
some controversies about their function [32-35]. The best
described forms are the mPRα and mPRβ proteins [33,35-
42], whereas mPRγ is less studied [20,28,30].
We have previously shown that mPRγ is expressed at the
apical cell membrane of ciliated cells in the mouse and
human fallopian tube, leading us to hypothesize that
mPRγ can be a mediator of rapid effects of P4 on ciliary
activity in mammals [20]. Monkkonen et al. (2007)
reported the expression of the mPRβ gene in a fallopian
tube cell line possessing secretory epithelial cell properties
[39], and Romero-Sanchéz et al. (2008) reported expres-
sion of the mPRβ and α protein in all epithelial cells of the
human fallopian tube, but the intracellular localization of
the receptors remained unclear [43]. In this study we dem-
onstrate a distinct membrane-associated localization of
both mPRβ and γ in ciliated cells of the fallopian tube in
mice and women. Whereas mPRγ is found at the base of
the cilia, mPRβ is located along the cilia themselves. Fur-
thermore, we show regulation of both mPRβ and γ by sex
steroid treatment in mice and a variable mPRβ expression
in fallopian tubes of women during the menstrual cycle.
Our results suggest the possibility for a cooperative role of
mPRβ and γ in gamete transport.
Methods
Antibodies, hormones and reagents
For Western blot analysis and immunohistochemistry stud-
ies, the following primary and secondary antibodies were
used: mPRβ [44], mPRγ [20], β tubulin-IV (T7941; Sigma-
Aldrich, St Louis, MO), PGR (sc-539; C-20; Santa Cruz Bio-
technologies Inc, Santa Cruz, CA) and FSHr (sc-7798; N-20;
Santa Cruz Biotechnologies Inc). The alkaline phosphatase
anti-rabbit IgG (T2191; Tropix, Bedford, MA), alkaline phos-
phatase anti-goat IgG (SC-2022; Santa Cruz Biotechnologies
Inc), TexasRed anti-rabbit IgG (TI-1000, Vector lab Inc., Bur-
ligame, CA) and TexasRed anti-mouse IgG (TI 2020; Vector
lab Inc.) were used as secondary antibodies.
Progesterone (P4) and 17-β-estradiol (E2) were from Sigma;
ICI 182,780 (Faslodex™, AstraZeneca) was purchased from
Tocris Cookson Ltd. (Bristol, UK), and CDB2914 was from
Organon (N.V. Organon, Oss, and Netherlands). Equine
gonadotropin (eCG; cat.no.G4877) was from Sigma-Aldrich
(Saint Louis, MO), and human chorionic gonadotropin
(hCG) was obtained from N.V. Organon. The protease
inhibitor cocktail was from Roche Diagnostics (Roche Com-
plete, Mannheim, Germany), and CDP-Star ready-to-use
developing system was from Tropix. All chemicals used in
immunohistochemistry or immunofluorescent staining,
included in kits or alone, were purchased from Vector Labo-
ratories, Inc., unless otherwise specified.
Animal studies
All experiments were performed with the approval of the
annual local ethics committee in Gothenburg, Sweden
(246/2007 to D.G.J. Larsson). The animals, 352 females
and three males C57BL/6 mice, used in these experiments
were obtained from Taconic M&B, Copenhagen, Den-
mark.
Experimental design and tissue preparation in mice
Tissue distribution of mPRβ in male and female mice
To examine the general tissue distribution of mPRβ, dif-
ferent organs from immature (21-day-old) male and
female mice (n = 3 biological replicates per sex), were col-Reproductive Biology and Endocrinology 2009, 7:89 http://www.rbej.com/content/7/1/89
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lected. Fat or connective tissues were immediately
removed from the tissues, and the samples were directly
frozen in liquid nitrogen for protein preparation and
Western blot analysis (see below for details).
Localization of mPRβ and γ proteins in the mouse fallopian tube
To investigate the localization of mPRs in the fallopian
tube, tissues from immature female mice (21-day-old)
were collected and fixed in 10% neutral buffered formalin
for immunohistochemistry analysis.
Regulation of mPRβ and γ in the fallopian tube of immature female 
mouse following hormonal treatment
The concentrations of E2 and P4 are very low in the imma-
ture mouse, allowing us to assess the effects of exogenous
steroid addition with limited interference by endogenous
steroids. To examine whether exogenous E2 and P4 regu-
late mPRβ and γ expression, individual groups of 21-day-
old female mice were therefore given one i.p. injection E2
(0.3 mg/kg) or P4 (4 mg/kg). To investigate whether the
nuclear estrogen receptors (ESRs) and PGRs are involved
in the regulation of mPR, we used the ESR antagonist ICI
182,780 (ICI, 8.3 mg/kg) and the PGR-A/B antagonist
CDB2914 (CDB, 1 mg/animal). All compounds were sus-
pended in 100 μl of sesame oil (Sigma). After 2 h and 6 h
of treatment, one group of animals (n = 5) was killed, and
the tissues were frozen immediately for RNA preparation.
To study the regulation of the mPR proteins, fallopian
tubes were sampled 6 h and 24 h after injection with
either E2 or oil and were frozen in liquid nitrogen for
Western blot analysis. Whereas RNA analyses were per-
formed on individual samples, pooling of tissue from ten
individual mice was required for each protein analysis.
Thus, the experiment with E2 and oil was repeated several
times to generate three independent pools of tissue from
each treatment group for the analyses of mPRβ and γ.
Regulation of mPRβ and γ in eCG-stimulated female mouse fallopian 
tube following hormonal treatment
In the mouse, the levels of expression of PGR and ESR are
increased after hormonal treatment [45-47]. Therefore, to
verify the effect of steroid treatment in a model expected
to have higher levels of nuclear receptors, as well as being
closer to a developmental stage when the control of gam-
ete transport becomes important, we also used a gonado-
tropin-primed mouse model. Immature female mice (21-
day-old) were given a single i.p. injection of 5 IU equine
Chorionic Gonadotropin (eCG). After 48 h, the mice were
injected i.p. with the steroid/antagonist and were sampled
after 2 h or 6 h, as described under experiment three.
Effects of gonadotropins on mPRβ and γ expression in 
mouse fallopian tube
To study the regulation of mPRβ and γ before and after
ovulation and to allow a comparison with human data
(see below), we used a mouse model where eCG was
administered as in experiment four. After 48 h, mice were
injected i.p. with 5 IU of human Chorionic Gonadotropin
(hCG). In mice given this treatment, serum E2 concentra-
tions are increased by 24 h after eCG administration,
reaching a peak after 48 h, whereas P4 concentration are
increased after post-hCG administration and peak around
48 h [46]. The serum levels of E2 and P4 in immature mice
upon treatment with eCG/hCG is similar to those of adult
cyclic mice [48]. At times 0, 48, 72 and 96 h from the
onset of the first injection, animals were killed by cervical
dislocation, and their fallopian tubes were dissected and
frozen in liquid nitrogen for Western blot analysis.
Human studies
Fallopian tube samples were obtained from 12 fertile
women, aged 2842 y, undergoing tubal ligations at the
Sahlgrenska University Hospital. Prior to the operation,
informed consent from the patients and approval by the
institutional committee on the use of human subjects in
Gothenburg (RS175-99 to A. Thurin) were obtained. All
women had a clinical examination before surgery and had
regular menstrual cycles (cycle length, 2532 days). No
woman had used hormonal medication within three
months of surgery. The menstrual phase of each patient at
the day of operation was classified based on previous
menstrual history, serum steroids and luteinizing hor-
mone-levels in urine [49]. A cross-section of the isthmus
part of the fallopian tube was taken from each patient.
One part was fixed with 10% neutral buffered formalin,
embedded in paraffin, sectioned and mounted. The
remainder was placed into cold saline solution prior to
freezing (-70°C) for later Western blot analyses.
RNA isolation and reverse transcription-polymerase chain 
reaction
Total cellular RNA was isolated from the fallopian tubes
of individual mice using the RNeasy Micro Kit (Qiagen,
Germany) according to the manufacturer's instructions
and was treated with an RNase inhibitor (Applied Biosys-
tems, Foster City, CA). A single batch of 0.5 μg of total
RNA from each sample was used to synthesize single-
stranded cDNA using High-Capacity cDNA Reverse Tran-
scription Kits (Applied Biosystems). Primers targeting the
cDNA sequence of mPRβ (sense, 5'-CGGCGGCTGCTT-
TCTGT-3' and antisense, 5'-TAAGGCCGTCGG-
TAGCGATA-'3), mPRγ (sense, 5'-CTCCCTAGGCTATTCC
GCATAG-3' and antisense, 5'-GGATGCCCTGCTCAT-
GGA-3') and GAPDH, used as an endogenous control
(sense, 5'-TGTGTCCGTCGTGGATCTGA-3' and antisense,
5'-ATGCCTGCTTCACCACCTTCT-3') were designed by
using Primer Express (Applied Biosystems) and purchased
from Cybergene AB, Stockholm, Sweden. The correspond-
ing cDNA fragments were denatured at 98°C for 2 min,
annealed at 59°C for 30 sec. The number of RT-PCR cycles
was chosen to generate detectable signals without
approaching saturation in any samples. After 30 cycles ofReproductive Biology and Endocrinology 2009, 7:89 http://www.rbej.com/content/7/1/89
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amplification, the PCR products were isolated by electro-
phoresis and visualized using ethidium bromide.
Taqman quantitative polymerase chain reaction
The Taqman QPCR reaction (quantitative polymerase
chain reaction) was performed with the ABI Prism 7000
Sequence Detector (Applied Biosystems). The dissocia-
tion graph showed only one specific amplicon product for
each target. For each amplification reaction, 20 ng cDNA,
500 nM of each primer and 1 × Sybr®Green PCR reaction
mix (Applied Biosystems) was combined into a final vol-
ume of 25 μl. The PCR parameters were set according to
the manufacturer's protocol. All reactions were performed
in duplicate for both target genes and endogenous con-
trols. The efficiencies of target and the endogenous con-
trols were similar. Because not all samples could be run at
the same time, one standard sample was run five times as
duplicates in all assays to compensate for possible run to
run variations. The expression of each target gene was nor-
malized to the endogenous control (GAPDH) by subtract-
ing the CT- value from the target gene with the CT-value
of the endogenous control. To compare levels relative to a
calibrator (mean of Group 1), ΔCT of group 1 was sub-
tracted from the ΔCT of each sample. Relative expression
is given by 2-ΔΔCt.
Protein extracts and Western blot analysis
All protein preparations of fallopian tube samples were
performed as described by Fujii et al., (2001) [50]. Sam-
ples from male and female mice used in the tissue distri-
bution experiment were prepared according to Bordier et
al. (1981) and Nutu et al., (2007). Thirty μg of protein
were run by electrophoresis on 412% one-dimensional
Bis-Tris gels (Novex, San Diego, CA, USA). In experiments
in which both mPRβ (1:5000), mPRγ (1:100), PGR
(1:250) and follicle stimulating hormone receptor (FSHr;
1:250) were assessed, the gels were cut into two pieces
along a line corresponding to approximately 60 kDa. The
section containing higher molecular weights was exposed
to antibodies against PGR, or FSHr, and the lower molec-
ular weight section was exposed to antibodies against
mPRβ or γ. Separate gels and membranes were run for the
two mPRs as they have very similar molecular masses. The
immunosignal-CDP-Star ready-to-use substrate for the
alkaline phosphatase system (Tropix, Bedford, MA, USA)
was used to visualize protein bands. Immunoblotted sig-
nals were quantified by densitometry using the Quantity
One Software package (version 4.2, BioRad, Hercules, CA)
directly after detection in a Fluor-S multi-imager (Bio-Rad
Laboratories, Sundbyberg, Sweden). The loading was
evaluated by staining the gels with Coomassie blue. Signal
intensities of the individual protein were normalized to
the gels stained with Coomassie blue and presented as
ratios that represent arbitrary densitometric units (ADU)
of relative abundance.
Immunohistochemical analysis and confocal microscopy
Single and dual-fluorescence immunohistochemistry
were based on the previously described methodology
[20]. Approximately 4 μm thick tissue sections were
placed on glass slides, deparaffinized, rinsed in ethanol
and re-hydrated through a series of decreasing concentra-
tions of ethanol. Antigens were retrieved by boiling with
an antigen unmasking solution for 20 min at 120°C,
which was followed by cooling in dH2O for 5 min. Non-
specific binding was blocked with the background sniper
(Biocare medical, Concord, CA USA), for 10 min at a
room temperature. The sections were incubated in a
humidified chamber at 4°C over night, with either a pol-
yclonal antibody against mPRβ at dilution of 1:600 or a
mouse monoclonal anti-β-tubulin IV mouse at a dilution
of 1:600 in TBS. The MACH 3 rabbit AP (alkaline phos-
phatase) polymer kit and MACH 3 mouse HRP (horse
radish peroxidase) polymer kit (Biocare Medical) were
used as the detection systems, and the immunostaining
was visualized by using Vulcan Fast Red Chromagen Kit
and Romulin AEC Chromagen Kit (Biocare Medical)
according to the manufacturer's protocol. Sections were
counter stained with hematoxylin, dehydrated through a
series of increasing concentrations of ethanol to clear the
tissue and cover-slipped. The immunostaining and detec-
tion of mPRγ protein were performed using the same pro-
tocol as previously reported [20]. Negative control slides
were prepared in an identical manner and processed with
a ready-to-use mouse or rabbit IgG negative control (Bio-
care Medical) instead of the primary antibody. Slides were
viewed on a Nikon EFD-3 (Nikon, Tokyo, Japan) micro-
scope under bright field optics and photographed. The
immunofluorescences on the slides were viewed on an
Axiovert 200 confocal microscope (Carl Zeiss, Jena, Ger-
many) equipped with a laser-scanning confocal imaging
LSM 510 META system (Carl Zeiss) and was photomicro-
graphed. Background settings were adjusted from exami-
nation of negative control specimens. Images of positive
staining were adjusted to make the optimal use of the
dynamic range of detection. Figures were composed in
Adobe Photoshop with minimal alteration for presenta-
tion and layout.
Statistical analysis
Data were analyzed using Minitab® Statistical Software
(Minitab Ltd., Coventry, UK). Differences between group
means were analyzed using the general linear model
(GLM). Post-hoc tests was applied were appropriate,
including Dunnet's test for multiple comparisons to a
control group or Bonferroni's test for comparisons
between all groups. Residual analyses were used to check
assumptions of normality and equality of variances and
log-transformed when appropriate. Data are presented as
mean ± SEM. P-values < 0.05 were considered statistically
significant.Reproductive Biology and Endocrinology 2009, 7:89 http://www.rbej.com/content/7/1/89
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Results
Tissue distribution of mPRβ in male and female mice
We previously reported the tissue distribution of mPRγ in
male and female mice [20]. [46]To determine the distri-
bution of mPRβ protein in the same model, Western blot
analysis was performed using a well-characterized anti-
body. The expression of mPRβ protein was confirmed by
a single band of 40 kDa in female reproductive tissues
(ovary, fallopian tube and uterus). High expression of
mPRβ was also detected in male testis, whereas lower lev-
els were observed in other tissues of both sexes (Fig. 1).
The liver and kidney of both male and female mice
showed the lowest, but still detectable, levels of mPRβ.
Localization of mPRβ and mPRγ proteins in the mouse 
fallopian tube
The mPRβ protein was expressed in the fallopian tube of
immature female mice (Fig. 2A). The localization was
confirmed by immunohistochemistry (2A.a and d) and
immunofluorescence (2A. g, i and j). The mPRβ was only
found in the cilia of epithelial cells facing the lumen of the
fallopian tube (c, d, f, and g). The identity of the cell type
expressing mPRβ was verified using β-tubulin IV, a spe-
cific marker for ciliated cells (2A. b, e and h). Confocal
microscopy also showed co-localization of mPRβ (green)
and β-tubulin (red) immunoreactivity (2A. i and j). The
localization of mPRβ was restricted to the upper part of
the epithelial cell cilia (2B.a), whereas mPRγ was associ-
ated with the apical membrane of the cells (2B. b1) as pre-
viously reported [20]. These results were also confirmed
using immunohistochemistry (2B.b1) and dual immun-
ofluorescence (2B.b2). Labeling with an antibody against
β-tubulin IV showed a strong staining restricted to the cilia
of epithelial cells (2B.c).
Regulation of mPRβ and mPRγ in the fallopian tube of 
immature female mouse following hormonal treatment
Considering that fallopian tubes from multiple mice are
required for each Western blot analysis of mPR protein,
we decided to first study the regulation of receptors on the
Western blot analysis of mPRβ in tissues of male and female mice Figure 1
Western blot analysis of mPRβ in tissues of male and female mice. Densitometric quantification is indicated by the 
bar graph. Data are presented as mean arbitrary density units normalized to total protein loading ± SEM from three biological 
replicates per tissue.
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Immunostaining for mPRβ, mPRγ and β-tubulin proteins in the mouse fallopian tube Figure 2
Immunostaining for mPRβ, mPRγ and β-tubulin proteins in the mouse fallopian tube. A: Immunohistochemical (a  
f) and immunofluorescent (g  j) detection of mPRβ and β-tubulin, a marker for ciliated epithelial cells. Sections immunolabeled 
for mPRβ were visualized with MACH 3 rabbit AP (a and d) and green florescence (g). The β-tubulin was stained with MACH 
3 mouse HRP (b and e) and red fluorescence (h). The panels' c and f are control sections where the primary antibody was 
omitted. A double staining was also performed using green and red fluorescent labels for mPRβ and β-tubulin, respectively (i). 
All fluorescence sections were subsequently counterstained with DAPI to visualized cell nuclei. Confocal microscopy in (j) is 
showing the overlapping fluorescence of two fluorochromes used. Tubal sections were labelled for mPRβ (green), β-tubulin 
(red) and merged (yellow). 2B: To facilitate a comparison of the localization of the mPRs, immunostaining for mPRβ (a) mPRγ 
(b1) β-tubulin (c) and dual staining of mPRγ (green) and β-tubulin (red) (b2) are also presented.
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mRNA level. As indicated in Fig. 3A, RT-PCR confirmed
the expression of both mPRβ mRNA and mPRγ mRNA in
immature mice.
Exposure to E2 rapidly and significantly decreased the
mRNA expression of mPRβ but not of mPRγ, which had
an opposite trend (Fig. 3B). The decrease in mPRβ mRNA
was reflected in a similar decrease in protein levels (Fig.
3C). There were no significant effects of P4, ICI or CDB on
either mPRβ and mPRγ gene expression two or six hours
post injection (Fig. 3B). The standard deviations (SD)
between the run to run samples were 0.008 cycles for the
2 h samples and 0.045 cycles for the 6 h samples and did
not significantly affect the results; thus, no run-to-run
compensation was included in the final calculations.
Regulation of mPRβ and mPRγ in eCG-stimulated female 
mouse fallopian tube following hormonal treatment
In the eCG-primed female mouse, E2 treatment did not
cause a significant decrease in the expression of mPRβ
mRNA at two hours, similarly to its effects in the imma-
ture mouse model. In contrast to the immature model, P4
treatment significantly down-regulated expression of
mPRβ at this time (two hours). The mPRγ expression was
also significantly reduced by P4 (six hours), whereas no
effects where observed with the injections of E2, ICI or
CDB (Fig. 4).
Effects of gonadotropins on mPRβ and mPRγ expression in 
mouse fallopian tube
Treatment of immature mice with eCG did not affect the
expression of the mPR proteins 48 h post injection. An
additional injection with hCG transiently reduced the
expression of mPRγ protein after 24 h, whereas the expres-
sion of mPRβ remained unaffected (Fig. 5).
Expression of mPRβ and mPRγ in fallopian tubes from 
cycling women
Similar to the localization in mice, human mPRβ was
found in the distal part of the cilia of epithelial cells (Fig.
6A; a, b), whereas mPRγ was associated with the apical
membrane of ciliated epithelial cells (Fig. 6A; d, e). West-
ern blotting of human fallopian tubes also demonstrated
expression of both mPRβ and mPRγ proteins with molec-
ular weights of about 40 kDa (Fig. 6B). The expression of
mPRγ in women sampled around ovulation was signifi-
cantly lower than the expression in preovulatory women
(Fig. 6B).
Discussion
This study demonstrates a specific expression of mPRβ
and mPRγ proteins in ciliary cells of both mouse and
human fallopian tube epithelia. In contrast to earlier
reports [43], we show a distinct expression of mPRβ on
the cilia proper and of mPRγ at the base of the same cilia.
We hypothesize that mPRβ and mPRγ have cooperative,
but still distinctive functions in controlling ciliary move-
ment and, thus, gamete transport in the fallopian tube of
mammals. A demonstrated down-regulation of both
mPRs after exogenous P4 treatment adds support to the
previously proposed roles of the mPRs as functional P4
receptors [12,29]
We previously reported a detailed tissue distribution of
mPRγ in male and female mice [20]. In the present study,
we show that the mPRβ protein is expressed in reproduc-
tive tissues such as fallopian tube, ovary and testis of both
male and female mice. In other species, including human,
pig, rat and fish, the expression of mPRβ has been
reported not only in reproductive tissues, but in non-
reproductive tissues as well, including brain, heart and
liver [29,31,34,36,38,40,44]. This was also the case in the
mouse; however, the relative expression level of mPRβ
between different organs appears to vary between species.
The mPRβ appears to be expressed more evenly between
tissues compared with mPRγ. In contrast to the high
expression level of mPRγ in liver, mPRβ was almost unde-
tectable in this organ. There were no marked differences in
expression between the sexes for mPRβ, except for the
reproductive tissues. We did not find a particularly high
level of mPRβ expression in the brain, as previously
reported [29,34]; however, this may be because we only
studied the general tissue distribution in pre-pubertal ani-
mals.
Membrane progesterone receptor β was found in the
motile cilia of epithelial cells in fallopian tube of both
mice and women. The co-localization of mPRβ and β-
tubulin IV, a cellular marker for cilia, also confirms the
specific localization. In contrast, Romero-Sánchez et al.
(2008) reported immunostaining of all epithelial cells,
including both secretory and ciliated cells, in the human
fallopian tube using the same mPRβ antibody as in our
study. However, the localization within these cell types
was unclear [43]. We have experienced that different fixa-
tion and staining techniques can give rise to a rather gen-
eral intracellular staining using this and other antibodies
(unpublished data). Qui et al. (2008) also show that the
staining technique can be crucial, as addition of Triton
X100 switched the staining by another antibody against
mPRβ from the plasma membrane to a general intracellu-
lar staining in porcine cumulus cells [40]. Therefore, it is
important to optimize the protocol to achieve the most
specific staining possible. Several other studies, which
used the same antibody used in the present study, report
a plasma membrane localization of mPRβ in different
cells and species, including human myocytes [33], human
T lymphocytes and Jurkat cells [51] and mouse gonado-
tropes [52]. Other studies report an intracellular localiza-
tion of mPRβ and γ, possibly in the endoplasmicReproductive Biology and Endocrinology 2009, 7:89 http://www.rbej.com/content/7/1/89
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Steroid-dependent regulation of mPRβ mRNA and mPRγ mRNA (A and B) and protein (C) in the fallopian tube of immature  female mice Figure 3
Steroid-dependent regulation of mPRβ mRNA and mPRγ mRNA (A and B) and protein (C) in the fallopian 
tube of immature female mice. Mouse ovary was included as a positive control in (A). Twenty-one-day-old female mice 
received an injection of E2, P4, the estrogen antagonist ICI 182,780, the progesterone antagonist CDB2914 or oil and sampled 
two or six hours later. The levels of mRNA are normalized to the endogenous control (GAPDH) and expressed in relative 
numbers to the control group as means ± SEM of five independent observations (B) whereas protein levels are presented as 
mean ± SEM of three independent pools, each consisting of tissue from ten mice (C). Groups differing significantly from the 
control group are indicated by asterisks (** for P < 0.01 and * for P < 0.05)
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reticulum [35,40,43,53]. The transcript for mPRβ has
endoplasmatic reticulum export and endocytosis internal-
ization motifs, which is in agreement with a potential
intracellular localization [40,54]. It is important to stress
that steroids easily pass the plasma membrane, thus the
ligand(s) for mPRβ could quite possibly reach the recep-
tor irrespective of its cellular localization.
Within the fallopian tube of mice and women, both
mPRβ and γ are expressed exclusively in the ciliary epithe-
lial cells. We previously reported that mPRγ was associ-
ated with the apical membrane at the base of the cilia of
these cells [20]. Here, we show that mPRβ is expressed on
the same cells, but in contrast to mPRγ, the receptors are
found on the cilia themselves. The close association of
both receptors with the cilia suggests an involvement in
the regulation of ciliary activity by P4. In the cow, P4
decreases ciliary beat frequency within 15 minutes, and
the effect cannot be blocked by a nuclear P4 receptor
antagonist [9]. The co-occurrence of both receptors in the
same cells also provides a possibility for a cooperative
role. Cooperative roles for different mPR subtypes have
been demonstrated previously in the induction of oocyte
maturation in fish and in the regulation of PGR transacti-
vation in human myometrial cells [33,55]. Interestingly,
recent studies indicate the stimulatory effects of progestins
on flagella activity and motility of fish and human sperm
are mediated through a mPR subtype, mPRα [56,57]. A
clear relationship between the abundance of the mPR pro-
tein on sperm membranes and sperm motility has been
observed both in fish and humans [56,57]. Taken together
the results suggest a possible widespread involvement of
mPRs as intermediaries in progesterone modulation of
the activities of ciliated and flagellated cells.
The classical PGR is also expressed in the fallopian tube;
however, there is somewhat conflicting data regarding its
distribution [45,46,58]. In the mouse, immunostaining
for PGR was reported in the nuclei of luminal epithelial,
stroma and smooth muscle cells [46,58], whereas in
women the staining for PGR was restricted to the nuclei of
epithelial and stromal cells [59]. In another study, no
immunostaining was found for the classical PGR in the
nuclei of any cell type in the mouse fallopian tube,
whereas an intense staining was demonstrated in cilia
proper [45], quite similar to the staining for mPRβ
reported here. In this context, it may be stressed that there
are no apparent sequence similarities between the classi-
cal PGR and mPRβ, thus little risk for one antibody to
have high affinity for the other receptor. Several studies
report a possible non-genomic, rapid signaling of P4
through PGR in different cell types [23,33,60]. Also, a
plasma membrane localization of the classical PGR has
also been suggested [14,61,62]. Together, this suggests
that the ciliated cells of the fallopian tubes are equipped
with a suite of P4 receptors, which all could be involved in
controlling the beating of the cilia or possibly being
involved in feedback systems by controlling receptor
expression.
There is accumulating evidence that the family of mPRs
(α, β and γ) act as receptors. Criteria, supporting a receptor
function of the mPRs include information on plausible
structure, tissue specificity, sub-cellular localization, ster-
oid binding, signal transduction, hormonal regulation
and biological relevance [12,29]. Although the aim of the
present study has not been to scrutinize the classification
of the mPRs as receptors, the generated data adds to the
body of observations supporting such a role. One impor-
Steroid-dependent regulation of mPRβ and γ in fallopian tubes of eCG-primed, immature mice Figure 4
Steroid-dependent regulation of mPRβ and γ in fallopian tubes of eCG-primed, immature mice. Forty-eight 
hours after eCG injection, the mice received an injection of E2, P4, the estrogen antagonist ICI 182.780, the progesterone 
antagonist CDB2914 or oil and were sampled two or six hours later. The levels of the target genes are normalized to the 
endogenous controls (GAPDH) and presented relative to the control group. Values are presented as mean ± SEM of five inde-
pendent observations. The significance is shown as * P < 0.05 compared to the control group.
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tant observation is the plasma-membrane-association of
mPRβ and mPRγ on the ciliary cells, i.e. a plausible sub-
cellular localization. Also, the location of mPRβ on cilia of
the fallopian tube, a cell-type known to respond rapidly
within minutes to P4, is coherent with a receptor-role of
mPRβ and mPRγ. Furthermore, treatment with exogenous
P4down-regulates both mPRβ and mPRγ in gonadotropin-
primed female mice within a few hours in the mouse fal-
lopian tube. Indeed, it is very common that steroid recep-
tors are regulated by their own ligand [29,30]. The
functional fish progestin 17, 20β-dihydroxy-4-pregnen-3-
one (17,20β-DHP) down-regulates mPRβ mRNA in the
ovary of the channel catfish [63]. In human myometrial
cells, however, P4 does not affect the expression of mPRβ
[33]. We could only demonstrate a down-regulation by P4
in gonadotropin-primed mice, but not in immature mice.
Thus, it appears that the regulation of mPRs by P4 differs
between species, tissues and developmental stages.
The regulation of mPRβ and mPRγ by exogenous P4 could
be mediated via a direct stimulation of P4 receptors on the
cililary cells, or for example by modulating the release of
gonadotropins. Receptors for FSH in the fallopian tube
have been reported, but their physiological function in
this organ is yet unknown [64]. In estrogen-primed, cas-
trated rats P4 induces the release of both FSH and LH [65].
This model resembles the eCG-injected immature mouse
model where the eCG injection induces endogenous
estrogen production. We could demonstrate a regulation
of both mPRβ and mPRγ by P4 in mice primed with eCG,
but not in immature mice. This observation would be
coherent with P4 regulating the mPRs via a hypothalamic/
pituitary action and a stimulated gonadotropin secretion,
although this hypothesis needs to be further tested. There
was a similar trend of a reduced expression of both mPRβ
and mPRγ in the estrogen-treated eCG-primed mice, con-
sistent with an expected feedback on the gonadotropin
Expression of mPRβ and γ in fallopian tubes of mice induced to ovulate by injections of eCG (0 h) and hCG (48 h) Figure 5
Expression of mPRβ and γ in fallopian tubes of mice induced to ovulate by injections of eCG (0 h) and hCG (48 
h). Mice were sampled at times 0, 48, 72 and 96 hours post eCG-injection and analyzed by Western blotting. Samples from ten 
mice were pooled and the values are presented as mean ± SEM of three independent pools for each group. All groups were 
compared with each other, applying Bonferroni's post-hoc test. The statistical significance is shown as * P < 0.05.
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Localization (A) and regulation (B) of mPRβ and γ in the human fallopian tube during the normal reproductive cycle Figure 6
Localization (A) and regulation (B) of mPRβ and γ in the human fallopian tube during the normal reproductive 
cycle. The expression of mPRβ (A, a), β-tubulin (A, b) and mPRγ (A, d-e) are visualized by immunohistochemistry using spe-
cific antibodies. Subpanels c and f are control sections where the primary antibody was omitted. Another membrane bound 
protein, the FSH receptor (FSH) and the nuclear progesterone receptors were also analyzed to confirm that the sample prep-
aration indeed contained membrane proteins. Sampled were obtained from patients in the follicular (group I), periovulatory 
(group II) and the luteal (group III) phase of the menstrual cycle. Protein levels of the mPRs are presented in the bar graph as 
arbitrary densiometric values normalized to whole protein in Coomassie blue staining. Values are presented as mean ± SEM of 
four independent observations. For mPRγ, assumptions for the general linear model was not met despite transformation of 
data (unequal variances), thus three independent t-tests (allowing unequal variances) were applied to compare stages I, II and III 
followed by a Bonferroni correction for multiple comparisons. The statistical significance is shown as * P < 0.05.
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release, but the effect was not statistically significant. On
the other hand, E2 rapidly and significantly reduced the
expression of mPRβ, but not mPRγ in the immature
mouse model, clearly suggesting a gonadotropin-inde-
pendent regulation. Tentative E2 and P4 response elements
have been identified upstream from both the mPRβ and
mPRγ genes [34], suggesting the possibility of a direct
effect mediated via the classical steroid receptors. Direct
regulation in vitro of mPRs by P4 and other progestin hor-
mones has also been demonstrated previously in human
myocytes and teleost ovaries [29,33]. As the travelling
cumulus complex actively produces and releases steroids
[15-18], the epithelium of the fallopian tube probably
encounters higher steroid levels for a brief time period
than do most cells in the body. Thus, it is possible that it
is not the circulating steroids that are most important for
regulating mPR expression in the fallopian tube, but
rather steroids produced inside the fallopian tube. Indeed,
the activation of sperm swimming by P4 is thought to be
due to a gradient of locally produced P4 as the spermato-
zoa approaches the ovum inside the fallopian tube [66].
Notably, there is no intra-tubal steroid production in
either the immature or the eCG model.
Access to samples from women undergoing tubal liga-
tions at different time points in their menstrual cycles
allowed us to start addressing the physiological regulation
of mPRs in the human fallopian tube. Both mPRβ and
mPRγ are expressed on the ciliated cells of the human fal-
lopian tube, similar to their location in mice. Interest-
ingly, the expression of mPRγ was lower in women
sampled close to mid cycle, i.e., around the time of ovula-
tion, whereas there was no clear regulation of mPRβ. The
general pattern of a down-regulation of mPRγ and a more
stable expression of mPRβ was also observed in mice
induced to ovulate via two injections with gonadotropins.
This pattern suggests that there are commonalities
between the regulation of mPRs in the fallopian tube of
mice and women, adding confidence to the use of mice as
a human model in this context. The lack of apparent reg-
ulation of mPRβ in both ovulating mice and women may
be somewhat difficult to interpret in relation to the results
from the steroid injections, as there indeed are marked
variations in the circulating steroid levels before and after
ovulation in both species. Possibly, more frequent sam-
pling could have revealed variations in the receptor
expression.
Conclusion
In conclusion, we have demonstrated the presence of
mPRβ and γ in ciliated cells of the fallopian tube of mice
and women and the regulation of these receptors by P4
and/or E2. These observations further strengthen the role
of the ciliated cells of the fallopian tube as important
physiological targets for P4. Taken together, our results
support the hypothesis of an involvement of the mPRs in
P4-regulated gamete transport in mammals.
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